PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
J Mol Cell Cardiol. Author manuscript; available in PMC 2010 December 2.
Published in final edited form as:
PMCID: PMC2995918
NIHMSID: NIHMS253704

Morphological Dynamics of Mitochondria – A Special Emphasis on Cardiac Muscle Cells

Abstract

Mitochondria play a critical role in cellular energy metabolism, Ca2+ homeostasis, reactive oxygen species generation, apoptosis, aging, and development. Many recent publications have shown that a continuous balance of fusion and fission of these organelles is important in maintaining their proper function. Therefore, there is a steep correlation between the form and function of mitochondria. Many major proteins involved in mitochondrial fusion and fission have been identified in different cell types, including heart. However, the functional role of mitochondrial dynamics in the heart remains, for the most part, unexplored. In this review we will cover the recent field of mitochondrial dynamics and its physiological and pathological implications, with a particular emphasis on the experimental and theoretical basis of mitochondrial dynamics in the heart.

Keywords: mitochondria, mitochondrial fission and fusion, mitochondrial dynamics, cardiac muscle, ventricular myocytes

1. Introduction

The name, “mitochondrion,” derived from the Greek words “mitos” (thread), and “chondros” (grain), describes two shapes of mitochondria that were observed by light microscopy around 150 years ago [1]. Recent advancements in imaging techniques have revealed that the shape of mitochondria in living cells is quite dynamic, constantly interchanging between thread-like and grain-like morphology through what we know now as the fusion and fission processes. These fusion and fission processes together with the mitochondrial movement have been termed “mitochondrial dynamics” [25].

The general hypothesis of the origin of mitochondria, that they evolved from the endosymbiosis of an aerobic bacterium with a protoeukaryotic cell, is based in part on the organelle’s double membrane structure, and on similarities of both mitochondrial DNA (mtDNA) and mitochondrial protein synthesis machinery to those of bacteria [1]. Mammalian mtDNA is 16-kb and circular, encoding 22 mitochondrial rRNAs, two mitochondrial tRNAs, and 13 proteins that make up parts of the oxidative phosphorylation complexes I, III, IV, and V. The structure of the mitochondrion is comprised of an outer and inner membrane, a narrow intermembrane space, and a large matrix. The outer membrane contains well-regulated channels that are relatively permeable to many ions and metabolic compounds [6, 7]. The inner mitochondrial membrane is invaginated, creating cristae structures that form microdomains of ions, nutrient molecules, ATP, ADP, and small soluble proteins [6]. The inner membrane contains the respiratory chain proteins for the generation of ATP, and many transporters that are important for the exchange of molecules in and out of the matrix. Contact sites, where the inner and outer mitochondrial membranes meet, is where complexes such as the porin/voltage dependent anion channel (VDAC), mitochondrial creatine kinase, and adenine nucleotide translocase (ANT) can be found [8]. These contact sites are also proposed to be the sites of mitochondrial fusion and fission [9].

Unlike the typical static kidney-bean shape shown in many textbooks, mitochondria are actually dynamic organelles which can move across great distances in the cell on microtubule networks, and undergo fusion or fission on average every two minutes in several cell types [1012]. The fusion and fission processes occur in a careful balance in order to maintain proper mitochondrial dynamics. An increase in fusion or a decrease in fission can lead to elongated, interconnected mitochondria, whereas a decrease in fusion or an increase in fission can lead to punctate, fragmented mitochondria (Figure 1). Mitochondria display a wide range of shapes, ranging from small vesicles to rods to tubules to branched reticular networks, within individual cells and in different cell types [13]. The mitochondria from many mammalian cell lines also generally cluster around the perinuclear area [13]. Additionally, giant mitochondria have been found in normal cells, aging cells, and cells with metabolic injuries [14, 15].

Figure 1
Model of the mechanism of mitochondrial fission and fusion in mammalian cells

Mitochondria cannot be generated de novo, but rather derive from existing mitochondria through division and synthesis and import of proteins and lipids. Every mitochondrion contains several copies of the mtDNA genome, which is maternally inherited. The mtDNA genome can be replicated multiple times during each cell cycle, and cells that have high levels of mutations in mtDNA (60–90%) can have dysfunctional oxidative phosphorylation and respiration [1618]. Defects in mitochondrial fusion can lead to accumulations of mtDNA mutations and, consequently, accumulations of dysfunctional mitochondria, apparently due to lack of complementation of mtDNA genomes and mixing of gene products. MtDNA mutations can result in many different diseases, one of which predominantly affects skeletal muscle, called myoclonic epilepsy associated with ragged-red fibers (MERRF). This disease is characterized by muscle weakness, increase in subsarcolemmal mitochondria, and lactic acidosis [19].

Fusion and fission processes require GTP hydrolysis and this expenditure of energy serves a purpose. Fusion between two or more mitochondria is important for the mixing of mitochondrial matrix contents [20]. Fused networks of connected mitochondria may facilitate the transmission of Ca2+ signals and membrane potential across distances within the cell [21, 22]. A decrease in mitochondrial fusion activity results in decreased mitochondrial oxygen consumption and membrane potential, as well as a decrease in mtDNA [23]. Fragmented mitochondria are thought to be easily transportable and allow for rapid mitochondrial trafficking to energy-demanding regions of the cell [21]. Disruption of mitochondrial fission results in disruption of mitochondrial recruitment and location [22, 24]. Mitochondrial fragmentation is also shown to be a necessary component for high glucose-induced respiration increase and reactive oxygen species (ROS) overproduction [25].

In this review we will describe the mammalian mitochondrial fission and fusion proteins, the regulation of these proteins, and their functional roles in health and disease. A special focus will be on the experimental and theoretical basis of mitochondrial dynamics in the heart.

2. The proteins involved in mitochondrial fusion and fission

Mitochondrial fusion is a complex process that involves the fusing together of four lipid bilayers. Mitochondrial fusion in mammals requires the two 85kD-GTPase isoforms mitofusin1 and mitofusin2 (Mfn1, Mfn2, Fzo1p in yeast) [26], which are outer mitochondrial membrane anchored proteins that contain two transmembrane domains connected by a small intermembrane-space loop, a cytosolic N-terminal GTPase domain and two cytosolic hydrophobic heptad-repeat coiled-coil domains (Figure 2) [2628]. Mfn1 and Mfn2 can form homo- and hetero-oligomers, or the coiled-coil domains of Mfn1 can interact in trans with Mfn1 on another mitochondrion which serves to tether adjacent mitochondria together [23, 29]. For a model of the fusion, see Figure 1. GTP hydrolysis is important in the fusion process. In cells where Mfn2 has a GTPase mutation, tethered mitochondria are found rather than fused mitochondria [29]. GTP hydrolysis may cause a conformation change in Mfn, but this process is not fully understood.

Figure 2
Structure of proteins involved in mammalian mitochondrial fusion and fission

Mfn1 and Mfn2 share 77% homology and have overlapping functions, as they can replace each other in Mfn-null cells [27]. However, there are functions that are unique to each Mfn. In embryo development, Mfn1−/− and Mfn2−/− mice die in midgestation and Mfn2−/− mice have defective placentation [30]. During mitochondrial fusion, Mfn1 and Mfn2 have different affinities to GTP and different GTPase activity [31, 32]. Mfn2 may also regulate mitochondrial metabolism. Mfn2 gene expression is reduced in type 2 diabetes and obesity, and expression is increased with exercise and weight loss [3335]. Another study suggests that insulin stimulates the expression of Mfn2 protein and inhibits the downstream MEK-dependent signaling pathway [36].

Mitochondrial fusion requires another dynamin family 100kD-GTPase, optic atrophy 1 protein (OPA1, Mgm1p in yeast, Figure 2), which is found in the intermembrane space or bound to the surface of the inner mitochondrial membrane, and is required to tether and fuse mitochondrial inner membranes [37, 38]. During mitochondrial fusion, after the outer membranes fuse, Mgm1p from both mitochondria interact in trans to tether and fuse the inner membranes [37]. In yeast, mitochondrial fusion requires a linker protein between outer and inner mitochondrial membrane proteins for proper fusion. Ugo1p found in the outer mitochondrial membrane connects Fzo1p to Mgm1p [39]. However, no homolog of this protein has been found in mammals.

Splicing of the mammalian OPA1 gene yields at least eight mRNA variants of OPA1 [40]. Post-translational proteolytic processing of OPA1 by mitochondrial processing peptidase (MPP) produces long isoforms that are anchored to the inner mitochondrial membrane, and cleavages at the S1 and S2 protease sites can yield additional short isoforms that are found in the intermembrane space [40, 41]. The following proteins are associated with proteolytic processing of OPA1: presenilin-associated rhomboid-like protein (PARL) at S2 [42, 43], the m-AAA proteases AFG3L2 [44] and paraplegin [45], and i-AAA protease Yme1 at S2 [41, 46, 47]. Loss of mitochondrial membrane potential regulates OPA1 cleavage by destabilizing the long OPA1 isoform and enhancing cleavage at S1 [41, 44, 45].

Loss of OPA1/Mgm1p results in mitochondrial fragmentation due to loss of mitochondrial fusion, and also leads to aberrations in cristae structure, suggesting that OPA1/Mgm1p plays a role in cristae maintenance [38, 43, 4851]. OPA1 controls the shape of cristae by forming self-oligomers comprised of both the long and short isoforms [42]. The tightness of cristae junctions correlates with OPA1 oligomerization, while BID disrupts OPA1 oligomers [42]. Mitochondria with Mgm1p GED mutants display a decrease in normal cristae structures [37]. In addition to its fusion and cristae remodeling roles, OPA1 is also important in the resistance to free radicals. Loss of function of the C. elegans OPA1-homologue, eat-3, leads to increased ROS sensitivity for injury either by paraquat, which produces superoxide radicals, or by the loss of mitochondrial superoxide dismutase sod-2 [52]. Moreover, these eat-3 mutants also overexpress sod-2 to prevent free radical damage [52].

Mammalian mitochondria undergo fission by the interaction of two proteins: dynamin-like protein 1 or dynamin-related protein 1 (DLP1/Drp1, Dnm1 in yeast), an 80–85-kD cytosolic GTPase, and human fission protein 1 (hFis1, Fis1p in yeast), a 17-kD outer mitochondrial membrane anchored protein. Overexpression of dominant negative DLP1 or dominant negative hFis1, or RNAi knockdown DLP1 or hFis1 induces mitochondrial elongation, which demonstrates that DLP1 and hFis1 are the required fission proteins [25, 53]. hFis1 is anchored in the membrane by a single C-terminal transmembrane domain, while the N-terminal cytosolic region consists of six α-helices that contain two tetratricopeptide repeat-like folds that are involved in protein interactions (Figure 2). Cross-linking and fluorescence resonance energy transfer (FRET) indicates that DLP1 and hFis1 bind together [54]. hFis1 transiently interacts with a DLP1-fission complex via the hFis1 TPR, and specifically the α1-helix plays a role in this interaction, perhaps serving as a regulator for DLP1-hFis1 interactions [25]. There is evidence that oligomerization of hFis1 may also play a role in mitochondrial fission, as overexpression of hFis1 oligomerization-defective mutants display reduced ability to induce mitochondrial fission [55]. In yeast, Fis1p requires the WD40-motif cytosolic adaptor proteins, Mitochondrial division 1 (Mdv1p) or Caffeine-resistant 4 (Caf4), that bind Dnm1p to Fis1p [5658]. There is no homolog of these proteins in mammals, yet other proteins are found, such as Bax and Endophilin B1, which will be discussed later. DLP1 is mainly localized in the cytosol and is recruited to the mitochondrial membrane by hFis1 to tips and constriction sites of mitochondria that are future sites of fission [59, 60]. DLP1 translocation depends on actin and microtubules, as disruption of F-actin or retrograde motor protein complex, dynein/dynactin, can attenuate fission and DLP1 recruitment to mitochondria [61, 62]. As studied in yeast with Dnm1, once at the mitochondria, DLP1 homo-oligomerizes into a ring formation around the mitochondrion [63]. DLP1 does not require hFis1 to assemble on mitochondria, as there was no difference in DLP1 distribution on mitochondria upon RNAi knockdown of hFis1 [53]. It is thought that because DLP1 and dynamin share a highly conserved GTPase domain and coiled-coil domain, that DLP1 also acts as a membrane-pinching mechanoenzyme. The coiled-coil regions of different DLP1 proteins can interact with each other and with the GTPase domain [64]. The self-assembly can stimulate the final step of fission, the hydrolysis of GTP, required for DLP1 constriction and disassembly [6567]. A model of this fission process is described in Figure 1. In addition, DLP1 and hFis1 are found on peroxisome organelles that catabolize fatty acids and H2O2. DLP1 also localizes to undefined cytoplasmic vesicles and the endoplasmic reticulum (ER) as well [68, 69].

Human membrane-associated RING-CH (MARCH)-5, also known as MITOL, is an E3 ubiquitin ligase that is found in the outer mitochondrial membrane [7072]. MARCH5 interacts with and ubiquitinates hFis1 and DLP1, as well interacts with Mfn2. RNAi of MARCH5 leads to mitochondrial elongation which indicates inhibition of mitochondrial fission. MARCH5 may also regulate trafficking of DLP1, as there is abnormal clustering of DLP1 in cells that express MARCH5 RING mutants [70].

Mitochondria protein (MTP18, Mdm33 in yeast), is a protein that faces the intermembrane space and is most likely anchored in the inner mitochondrial membrane [73]. MTP18 expression is activated by phosphatidylinositol (PI) 3-kinase signaling [74]. Overexpression of MTP18 leads to mitochondrial fragmentation, whereas RNAi of MTP18 leads to elongated mitochondria. Overexpression of hFis1 leads to mitochondrial fragmentation via the known DLP1-mediated pathway [25]. However, this hFis1-induced fragmentation was suppressed by MTP18 knockdown, suggesting that hFis1 may depend on MTP18 [73]. The mechanism of how MTP18 participates in fission of the inner mitochondrial membrane still remains unknown.

3. Post-translational regulation of mitochondrial fusion and fission

There are two types of mitochondrial fission, one being physiological, and the other pathological (which will be described in the next section). Mitochondrial fission can occur rapidly and reversibly by an increase in cytosolic Ca2+, and requires mitochondrial Ca2+ uptake, suggesting an intramitochondrial Ca2+ component to regulating mitochondrial fission machinery [75]. DLP1 is regulated covalently by ubiquitination and sumoylation [71, 76, 77], or phosphorylation. DLP1 phosphorylation and dephosphorylation is controlled by cytosolic Ca2+ signaling pathways. DLP1 can be phosphorylated by cyclin B1, cAMP, or CaM kinase 1α, and dephosphorylated by calcineurin pathways [7881]. Phosphorylation in the DLP1 GTPase effector domain (GED) at Ser600 by activation of Ca2+/calmodulin-dependent protein kinase 1α (CaMK1 α) has been associated with increase in DLP1 translocation to mitochondria and increase in DLP1 affinity for hFis1 [78]. Phosphorylation in the DLP1 GED at Ser585 by activation of Cdk1/cyclin B protein kinase complex has been shown to induce mitotic mitochondrial fragmentation. Phosphorylation by PKA in the DLP1 GED at Ser637 decreases GTPase activity and prevents mitochondrial fragmentation [79]. Similarly, DLP1 translocates to mitochondria in a calcineurin-dependent manner in dysfunction-induced fragmentation, which requires DLP1 Ser637 [81]. Additionally, phosphorylation by cyclic AMP-dependent protein kinase at DLP1 GED at Ser656 and dephosphorylation by calcineurin is regulated by sympathetic tone, Ca2+ levels, and cell viability [80]. In a study of patients with chronic heart failure an association was found between calcineurin activation and an increase in peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), an upstream regulator of lipid and glucose oxidative metabolism, and mRNA levels of proteins involved in degradation, fusion, and fission of mitochondria [82].

4. Mitochondrial dynamics in cell death

Although still controversial, there is evidence suggesting that mitochondrial morphology proteins are important in cell death pathways. Preventing mitochondrial fission through inhibition of DLP1 or hFis1 can delay or inhibit the markers of apoptosis such as cytochrome c release induced by staurosporin, actinomycin D, etoposide, or ER signals [25, 53, 83, 84]. Conversely, excessive mitochondrial fragmentation caused by the overexpression of hFis1 leads to apoptosis [25, 85].

In neonatal rat ventricular myocytes, H9c2 cells, bovine aortic endothelial cells, and mouse aortic smooth muscle cells, mitochondrial fragmentation occurs in the early stages of apoptosis [86]. Hyperglycemic conditions cause mitochondrial fragmentation, ROS increase, mitochondrial permeability transition (MPT), and cytochrome c release in these cardiovascular cells. Blocking mitochondrial fission can block ROS, MPT and cytochrome c release. Also bongkrekic acid, the adenine nucleotide translocase inhibitor, can prevent MPT in these conditions [86]. In another study, it was shown that C2-ceramide in neonatal rat cardiomyocytes were able to cause mitochondria to fragment and apoptosis to be activated. Also, cardiomyopathy was induced by doxorubicin treatment, which caused mitochondrial fragmentation and apoptosis [87]. These findings indicate a link between mitochondrial fragmentation and apoptosis in heart.

The link between mitochondrial morphology and apoptosis has been mainly explored in non-cardiovascular cells. Ca2+ is an important regulator of apoptosis, and prolonged ER Ca2+ depletion due to thapsigargin can lead to mitochondrial fragmentation and apoptosis [88, 89]. ER Ca2+ depletion causes an accumulation of unfolded or misfolded proteins in the ER, leading to ER stress pathways. If protein folding cannot be restored, apoptosis is triggered and can be mediated by the mitochondria and/or activation of proapoptotic kinases [90]. However, this apoptosis can be blocked by expression of mutant DLP1-K38A, a dominant negative DLP1 [75]. Mitochondrial Ca2+ uptake is important in BAP31-induced apoptosis or BH3-only BIK activation, as mitochondrial Ca2+ uptake increases DLP1 recruitment to the mitochondria, mitochondrial fragmentation, and apoptosis [84, 91].

Mitochondrial fission proteins also associate with proapoptotic proteins. It was demonstrated that endophilin B1/Bif1 triggers Bax and Bak (proapoptotic Bcl2 family proteins) activation upstream of mitochondrial fragmentation [92]. Subsequently, Bax and DLP1 colocalize together at scission sites on mitochondria [93]. After Bax translocation to the mitochondria, DLP1 becomes stabilized on the mitochondria, which correlates with a Bax/Bak-dependent sumoylation of DLP1 [94].

During apoptosis, mitochondrial morphology proteins, such as DLP1 and OPA1 have a role in addition to fission. DLP1 has a role in remodeling and opening cristae, which requires a functional permeability transition pore [91]. OPA1 also serves a function in apoptosis, and has been shown to be released during apoptosis with cytochrome c [95]. Downregulation of OPA1 causes cells to undergo apoptosis [50]. DLP1 and OPA1 may be involved in the release of cytochrome c. DLP1 is thought to facilitate mitochondrial outer membrane permeabilization (MOMP) through mitochondrial fragmentation. However, DLP1 may also have a role in MOMP. Upon thapsigargin treatment, cytochrome c was released without mitochondrial fragmentation, yet, cytochrome c release was inhibited when DLP1 was inhibited [75]. In another study, a chemical inhibitor of DLP1, mdivi-1, was used and partially blocked apoptosis by inhibiting MOMP in cells. In vitro, mdivi-1 blocked Bid-activated Bax/Bak dependent cytochrome c release. Taken together this suggests that DLP1 can regulate MOMP independent of the mitochondrial fission pathway, perhaps by directly modulating MOMP [96]. It is important to note, though, that apoptosis can occur without the fusion or fission proteins [83, 94, 97100].

5. Mitochondrial morphology and human disease

The importance of functional mitochondrial morphology is apparent as morphological defects are related to many human diseases. These include myopathies, diabetes mellitus, liver diseases, neurodegeneration, aging, and cancer [101]. Mutations in mitochondrial fission can be lethal. A female infant with a dominant-negative mutation in DLP1 only lived for 37 days, and had defects in fission of mitochondria and peroxisomes. The patient had microcephaly, abnormal brain development, optic atrophy and hypoplasia, and metabolic abnormalities [102]. RNAi against DLP1 is lethal in C. Elegans embryos before 100 days [59]. Mutations in mitochondrial fusion can also be lethal. Mice with mutations in Mfn1, Mfn2, or OPA1 cannot survive past midgestation [27]. Downregulation of OPA1, Mfn1, or Mfn2 results in mitochondrial fragmentation, a reduction in oxygen consumption, and a decrease in mitochondrial membrane potential [23]. Mfn2 mutations cause peripheral neuropathy-Charcot-Marie-Tooth subtype 2A, characterized by defects in axonal neurons [103, 104]. In addition, OPA1 is mutated in dominant optic atrophy, the defect in mitochondrial distribution and loss of retinal ganglion cells resulting in optic nerve atrophy [105]. Therefore, along with mtDNA mutations, mutations affecting mitochondrial fusion and fission proteins are a major source of human disease.

6. Mitochondrial dynamics in the heart

The great majority of work done so far on mitochondrial dynamics has utilized cultured cells because of the ease in performing live-cell imaging in these preparations. The mitochondria in these cultured cells show dramatic motility and morphologic changes. This robust mitochondrial dynamism could be a result of cell culture, which promotes microtubule-directed mitochondrial trafficking and thus mitochondrial fission and fusion [106]. This high degree of mitochondrial dynamics is considered not applicable to native tissues like adult heart, liver, kidney, etc. Electron micrographs of adult cardiac muscle cells, especially ventricular myocytes, show that mitochondria are numerous, making up about 35% of the cell volume, and that mitochondria are highly organized and compacted between contractile filaments and next to T-tubules. This crystal-like pattern of mitochondria raises an interesting question: do the mitochondria in adult ventricular myocytes also undergo physiological fission, fusion, and movement just like other cell types? This important question has just begun to draw some research attention very recently and thus the definitive answers are still lacking. Intuitively, one could imagine that there is no need for mitochondria in adult ventricular myocytes to go through fission, fusion, and movement because they are being anchored by cytoskeleton, crowded among themselves in a space that is surrounded by contractile proteins and Z-lines. In dichotomy, however, all mitochondria have a limited life span and their biogenesis, turnover, autophagy, and maintenance of genomic integrity are dependent critically on fission, fusion, and motility [107, 108]. Intriguingly, there are several studies indicated that all major proteins involved in mitochondrial fission and fusion do exist in adult hearts. Using Northern and Western blot to screen the expression of Mfn1 and Mfn2 in various adult human tissues, including heart, pancreas, skeletal muscle, brain, liver, placenta, lung, and kidney, one research group has found two Mfn1 transcripts in these human tissues, interestingly, with the highest amount in heart [109]. The group also found that while Mfn2 mRNA was abundantly expressed in heart and muscle tissue but expressed only at low levels in other tissues. The expression of Mfn1 and Mfn2 in rat and mouse heart has also been detected by RT-PCR [110, 111]. The fission protein hFis1 has been shown to be ubiquitously expressed in isolated rat mitochondria from many tissues, including heart [112]. The identification of DLP1 mRNA in adult human tissues was detected by northern blot analysis that showed high levels in skeletal muscle, heart, kidney and brain [113]. Using RT-PCR, four mRNA transcripts for OPA1 were identified in adult mouse hearts [114]. These four OPA1 splice variants produced six distinctive protein bands in hearts suggested that OPA1 isoforms undergo posttranslational modification. Although all these studies convincingly show that the mitochondrial fission and fusion proteins exist in heart, it should be noted that heart consists numerous cell types such as fibroblasts, endothelial cells, vascular smooth muscle cells, and cardiac muscles. To be sure, these experiments should be repeated by using purified isolated cardiac myocytes.

The identification of these fission and fusion proteins in adult heart, however, has not yet been implicated in their functional role of dynamically controlling mitochondrial morphology in adult cardiac muscle cells. The reasons for the lack of this information could be in part due to the technical difficulties in imaging mitochondrial morphology in living adult ventricular myocytes. The morphology of normal mitochondria tends to be big and cylindrical- or ovular shaped, averaging around 0.5–1 μm in width and 1–2 μm in length [1]. The dimension of an adult ventricular myocyte is approximately 120 μm × 20 μm × 10 μm. There are several thousands of mitochondria situated by-and-large orderly in a single cell. This is the major reason why the confocal images taken from myocytes loaded with mitochondria-targeted fluorescent probes show a very regular pattern of mitochondrial distribution (Fig. 3A). Due to the limitation in the spatial resolution (~200 nm for x–y axis and ~ 500 nm for z axis), confocal microscopy, unlike electron microscopy, may not be able to distinguish more subtle differences between mitochondria when they are packed near each other. It has long been known that the electron micrograph of adult ventricular myocytes shows that the mitochondria located around the nucleus, between the myofibrils, and beneath the sarcolemma, appear to have different morphology and distribution, as well as different oxidative metabolic activities [115, 116]. Figure 4A shows such an image that we have obtained from longitudinal sectioning of an adult rat ventricular myocyte. The mitochondria clustered near the poles of the nucleus (N) are generally more irregularly distributed with a globular shape and a higher degree of variation in size. Interfibrillar (I) mitochondria are usually aligned in longitudinal rows between the myofibrils. They are elongated and usually about the same length as a sarcomere. However, some mitochondria are clearly fragmented and are in contact with neighboring mitochondria (Fig. 4B). These more subtle variations among the interfibrillar mitochondria can be manifested more clearly in the electron micrography taken from transversely sectioned cardiac myocytes (Fig. 4C). In this image, mitochondria are “wrapped” partially around the myofilaments with certain degrees of variations. This close apposition of mitochondria to the contractile machinery strategically allows mitochondria to deliver ATP more efficiently to the sites where energy demands are high. Subsarcolemmal (S) mitochondria are also varied in size and shape, being rod-like, globular, or horseshoe-like. These distinct patterns of mitochondrial distribution in different regions of adult ventricular myocytes may suggest a spatial and temporal heterogeneity of mitochondrial dynamics in adult ventricular myocytes. It can be hypothesized that fission and fusion could occur in a timely manner for the perinuclear and subsarcolemmal mitochondria but much rarely for the interfibrillar mitochondria. For comparison, Figure 3B shows that both thread-like and grain-like morphology of mitochondria co-exist in the cultured neonatal ventricular myocyte. This appearance of mitochondrial distribution is similar to other types of culture cells for which the mitochondria are usually going through fission, fusion, and movement.

Figure 3
Mitochondrial morphology in adult and neonatal rat ventricular myocytes
Figure 4
Different populations of mitochondria in the adult ventricular cardiomyocyte

Another important feature about the distribution of mitochondria in the adult ventricular myocyte is their proximity to the sarcoplasmic reticulum (SR), some of them are located as close as 37 nm to the foot of the SR ryanodine receptor (RyR) foot [117]. Thereby, mitochondria are located within microdomains of high micromolar range Ca2+ during excitation-contraction coupling and are poised for both regulating localized cellular Ca2+ homeostasis and ATP generation, linking energy metabolism to excitation-contraction coupling (Fig. 5). The heart beats perpetually during their life span with a resting heart rate varies significantly among different animal species (e.g. 70 beats per minute in human and 450 beats per minute in mouse). In addition, the heart rate could change quickly under sympathetic and parasympathetic innervations. Therefore, the generation of ATP by mitochondria must be regulated effectively to meet the challenges in balancing energy demand and supply. It has become more evident that mitochondria use Ca2+ as a key regulator for controlling their metabolic activities [118]. During the excitation-contraction cycles, mitochondria sequester a small amount of Ca2+ that activates several enzymes involving in the ATP generating machineries. This signal cascade process, which ensures the homeostasis of bioenergetics in beating heart, has been termed excitation-contraction-metabolism coupling [119, 120]. It should be noted that this Ca2+ coupling between mitochondria and SR/endoplasmic reticulum (ER) for modulating oxidative metabolism occurs in numerous cell types [121]. One intriguing question is: do the mitochondrial dynamics play any role in excitation-contraction-metabolism coupling? Very interestingly, recent studies have shown that Ca2+ can regulate mitochondrial fission, fusion and motility [75, 122124]. Moreover, it has been reported that a new function of Mfn2 is to tether the endoplasmic reticulum and mitochondria to control the efficiency of mitochondrial uptake of Ca2+[125]. Although it is still not known whether this Mfn2 tethering mechanism also exists in heart, this new discovery exemplifies again the multiple roles of mitochondrial dynamics in regulating cell function.

Figure 5
The role of mitochondria in excitation-contraction-metabolism coupling in the cardiac myocyte

Taken together the above-mentioned experimental and theoretical evidence, several distinct aspects about mitochondrial dynamics can be raised in adult ventricular muscle cells: 1) the normal fusion/fission machinery (proteins) appears to exists, 2) the requirement of mitochondria regeneration, turnover, autophagy, genomic protection suggests the need for fission and fusion, 3) the motility is minimal and could vary among different mitochondrial populations, 4) a four-dimensional (x, y, z axis and time) live-cell imaging is needed to detect possible movements like mitochondria winding slowly through the myofibrils in the third dimension, and 5) the possible tethering of mitochondria with SR implicates that the Ca2+ concentrations in microdomains may play a crucial role in regulating mitochondrial fission, fusion, and motility.

In other type of cardiac muscle cells, some recent reports demonstrated the physiological and pathological implications of mitochondrial dynamics. In embryonic stems cells, it has been demonstrated that anaerobic glycolytic metabolism has to be transformed into the more efficient mitochondrial oxidative metabolism for cardiac differentiation [126]. This energetic switch might be manipulated by modifying the copy number of regulators of mitochondrial fusion and fission. Therefore, mitochondria dynamics could be critically in regulating the differentiation of stem cells into a functional cardiac phenotype. Interestingly, in day 12 rat embryo, the mitochondria morphology in heart muscle cells are randomly distributed with both rod-like and spherical shape [127]. This may suggest that myocytes are undergoing a transition from a glycolytic state with more fragmented mitochondria to an oxidative state with more fused mitochondria. Therefore, mitochondrial dynamics may be more pronounced during the early development of cardiac muscle cells.

In cultured neonatal ventricular myocytes, we have demonstrated that inhibition of mitochondrial fission by overexpressing cells with a dominant-negative mutant form of DLP1, DLP1-K38A prevented the overproduction of reactive oxygen species (ROS), mitochondrial permeability transition, and subsequent cell death under sustained high glucose condition, suggesting that mitochondrial fission is an upstream factor for these events [86]. Similarly, treating cultured neonatal ventricular myocytes with ceramides affects mitochondrial dynamics and promotes mitochondrial fission that leads to apoptosis [87]. These studies suggest that mitochondrial fission may be involved in ROS homeostasis and oxidative stress-mediated cell injury.

In contrast to normal cardiac mitochondria, there are cases of cardiac disease, including end-stage dilated cardiomyopathy, myocardial hibernation, cardiac rhabdomyoma, and ventricular-associated congenital heart diseases, where mitochondria were found to be disorganized and abnormally small [128133]. In one case of Tetralogy of Fallot, electron micrographs show disorganized clusters of fragmented mitochondria located away from contractile filaments, and the diameter of one mitochondrion was measured to be as small as 0.1 μm [133]. On the other hand, in senescent cardiomyocytes, accumulations of big and defective mitochondria correlate with age [134]. Using long-term culture of neonatal rat ventricular myocytes as an experimental model for studying aging, inhibition of autophagy with 3-methyladenine caused only moderate accumulation of “giant” mitochondria but drastically increased numbers of small mitochondria [134]. The authors conclude that the interplay between mitochondrial fission and autophagy control the rate of mitochondrial turnover and this balance may be disturbed in aging heart cells resulting in more giant mitochondria that were seen in aging heart. All together this suggests that there is a relationship between mitochondrial morphology and pathogenesis of cardiac disease, though this has not yet been explored in greater details.

7. Perspectives

Mitochondrial dynamics has drawn much research attention, especially during the last ten years. This is mostly due to the recent accumulation of vast knowledge indicating the biological significance of mitochondrial fission, fusion, and movement. One can appreciate that, in numerous cell types, the separation between mitochondria-mediated life versus death resides in the finest balance between fission and fusion. In cardiac muscle cells, this important aspect of mitochondrial research is mostly missing. This could be in part due to the intuition that there is no need for the mitochondria in adult ventricular myocytes to have fission and fusion processes due to their tight organization. Intriguingly, the heart appears to have higher levels of proteins involved in mitochondria dynamics than other tissue studied. It is plausible that these proteins may be involved in cellular signaling processes such as the regulation of electron transport chain activity or the regulation of the permeability transition pore in addition to, though still lacking experimental evidence of, fission and fusion. As described earlier, translocation of DLP1 may involve the steps of phosphorylation/dephosphorylation by signaling proteins such as cAMP dependent protein kinase and calcineurin. Moreover, activation of the fission process does not necessarily always end up with mitochondrial fragmentation, especially during the early and intermediate stages of activation [135]. We have recently obtained data showing that translocation of DLP1 to mitochondria is an earlier event for Ca2+ mediated ROS generation in adult rat ventricular myocytes (Hom and Sheu, unpublished results). Finally, the mitochondria dynamics could be an integral part of the regulation of cellular bioenergetics, redox signaling, Ca2+ homeostasis, differentiation, and aging for heart muscle cells. Hopefully, this review may catalyze additional activities in this important area of heart research.

Acknowledgments

We thank Drs. Yisang Yoon, Paul Brookes, George Porter, Gisela Beutner, and Robert Feissner for their comments on our manuscript and members of Mitochondrial Research & Innovation Group for their collaboration Thank you to Karen Bentley from the University of Rochester Electron Microscope Research Core for her help in obtaining the electron micrographs of heart. This work was supported by National Institute of Health grants HL33333 (to S-S.S.).

References

1. Scheffler IE. Mitochondria. 1. Wiley-Liss; 1999.
2. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol. 2007 Nov;8(11):870–9. [PubMed]
3. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, et al. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A. 2008 Dec 19; [PubMed]
4. Suen DF, Norris KL, Youle RJ. Mitochondrial dynamics and apoptosis. Genes Dev. 2008 Jun 15;22(12):1577–90. [PubMed]
5. Szabadkai G, Simoni AM, Bianchi K, De Stefani D, Leo S, Wieckowski MR, et al. Mitochondrial dynamics and Ca2+ signaling. Biochim Biophys Acta. 2006 May–Jun;1763(5–6):442–9. [PubMed]
6. Mannella CA. Structure and dynamics of the mitochondrial inner membrane cristae. Biochim Biophys Acta. 2006 May–Jun;1763(5–6):542–8. [PubMed]
7. Shoshan-Barmatz V, Israelson A, Brdiczka D, Sheu SS. The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death. Curr Pharm Des. 2006;12(18):2249–70. [PubMed]
8. Brdiczka DG, Zorov DB, Sheu SS. Mitochondrial contact sites: their role in energy metabolism and apoptosis. Biochim Biophys Acta. 2006 Feb;1762(2):148–63. [PubMed]
9. Reichert AS, Neupert W. Contact sites between the outer and inner membrane of mitochondria-role in protein transport. Biochim Biophys Acta. 2002 Sep 2;1592(1):41–9. [PubMed]
10. Frederick RL, Shaw JM. Moving mitochondria: establishing distribution of an essential organelle. Traffic. 2007 Dec;8(12):1668–75. [PMC free article] [PubMed]
11. Boldogh IR, Pon LA. Mitochondria on the move. Trends Cell Biol. 2007 Oct;17(10):502–10. [PubMed]
12. Shaw JM, Nunnari J. Mitochondrial dynamics and division in budding yeast. Trends Cell Biol. 2002 Apr;12(4):178–84. [PMC free article] [PubMed]
13. Yoon Y. Sharpening the scissors: mitochondrial fission with aid. Cell Biochem Biophys. 2004;41(2):193–206. [PubMed]
14. Tandler B, Hoppel CL. Studies on giant mitochondria. Ann N Y Acad Sci. 1986;488:65–81. [PubMed]
15. Ogawa K, Noguchi H, Tsuji M, Sasaki F. Starvation induces the formation of giant mitochondria in gastric parietal cells of guinea pigs. J Electron Microsc (Tokyo) 2003;52(2):217–25. [PubMed]
16. Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10614–8. [PubMed]
17. Nakada K, Inoue K, Chen CS, Nonaka I, Goto Y, Ogura A, et al. Correlation of functional and ultrastructural abnormalities of mitochondria in mouse heart carrying a pathogenic mutant mtDNA with a 4696-bp deletion. Biochem Biophys Res Commun. 2001 Nov 9;288(4):901–7. [PubMed]
18. Yoneda M, Miyatake T, Attardi G. Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol Cell Biol. 1994 Apr;14(4):2699–712. [PMC free article] [PubMed]
19. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 2006 Jun 30;125(7):1241–52. [PubMed]
20. Legros F, Lombes A, Frachon P, Rojo M. Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell. 2002 Dec;13(12):4343–54. [PMC free article] [PubMed]
21. Skulachev VP. Mitochondrial filaments and clusters as intracellular power-transmitting cables. Trends Biochem Sci. 2001 Jan;26(1):23–9. [PubMed]
22. Szabadkai G, Simoni AM, Chami M, Wieckowski MR, Youle RJ, Rizzuto R. Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis. Mol Cell. 2004 Oct 8;16(1):59–68. [PubMed]
23. Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem. 2005 Jul 15;280(28):26185–92. [PubMed]
24. Frieden M, James D, Castelbou C, Danckaert A, Martinou JC, Demaurex N. Ca(2+) homeostasis during mitochondrial fragmentation and perinuclear clustering induced by hFis1. J Biol Chem. 2004 May 21;279(21):22704–14. [PubMed]
25. Yu T, Fox RJ, Burwell LS, Yoon Y. Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1. J Cell Sci. 2005 Sep 15;118(Pt 18):4141–51. [PubMed]
26. Santel A, Fuller MT. Control of mitochondrial morphology by a human mitofusin. J Cell Sci. 2001 Mar;114(Pt 5):867–74. [PubMed]
27. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol. 2003 Jan 20;160(2):189–200. [PMC free article] [PubMed]
28. Legros F, Malka F, Frachon P, Lombes A, Rojo M. Organization and dynamics of human mitochondrial DNA. J Cell Sci. 2004 Jun 1;117(Pt 13):2653–62. [PubMed]
29. Eura Y, Ishihara N, Yokota S, Mihara K. Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion. J Biochem. 2003 Sep;134(3):333–44. [PubMed]
30. Chen H, McCaffery JM, Chan DC. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell. 2007 Aug 10;130(3):548–62. [PubMed]
31. Ishihara N, Eura Y, Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci. 2004 Dec 15;117(Pt 26):6535–46. [PubMed]
32. Neuspiel M, Zunino R, Gangaraju S, Rippstein P, McBride H. Activated mitofusin 2 signals mitochondrial fusion, interferes with Bax activation, and reduces susceptibility to radical induced depolarization. J Biol Chem. 2005 Jul 1;280(26):25060–70. [PubMed]
33. Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J, et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes. 2005 Sep;54(9):2685–93. [PubMed]
34. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, et al. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol. 2005 Aug 15;567(Pt 1):349–58. [PubMed]
35. Mingrone G, Manco M, Calvani M, Castagneto M, Naon D, Zorzano A. Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? Diabetologia. 2005 Oct;48(10):2108–14. [PubMed]
36. Pawlikowska P, Gajkowska B, Orzechowski A. Mitofusin 2 (Mfn2): a key player in insulin-dependent myogenesis in vitro. Cell Tissue Res. 2007 Mar;327(3):571–81. [PubMed]
37. Meeusen S, DeVay R, Block J, Cassidy-Stone A, Wayson S, McCaffery JM, et al. Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell. 2006 Oct 20;127(2):383–95. [PubMed]
38. Griparic L, van der Wel NN, Orozco IJ, Peters PJ, van der Bliek AM. Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem. 2004 Apr 30;279(18):18792–8. [PubMed]
39. Sesaki H, Jensen RE. Ugo1p links the Fzo1p and Mgm1p GTPases for mitochondrial fusion. J Biol Chem. 2004 Jul 2;279(27):28298–303. [PubMed]
40. Delettre C, Griffoin JM, Kaplan J, Dollfus H, Lorenz B, Faivre L, et al. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet. 2001 Dec;109(6):584–91. [PubMed]
41. Song Z, Chen H, Fiket M, Alexander C, Chan DC. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol. 2007 Aug 27;178(5):749–55. [PMC free article] [PubMed]
42. Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006 Jul 14;126(1):177–89. [PubMed]
43. Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K, et al. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell. 2006 Jul 14;126(1):163–75. [PubMed]
44. Duvezin-Caubet S, Koppen M, Wagener J, Zick M, Israel L, Bernacchia A, et al. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol Biol Cell. 2007 Sep;18(9):3582–90. [PMC free article] [PubMed]
45. Ishihara N, Fujita Y, Oka T, Mihara K. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 2006 Jul 12;25(13):2966–77. [PubMed]
46. Griparic L, Kanazawa T, van der Bliek AM. Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavage. J Cell Biol. 2007 Aug 27;178(5):757–64. [PMC free article] [PubMed]
47. Guillery O, Malka F, Landes T, Guillou E, Blackstone C, Lombes A, et al. Metalloprotease-mediated OPA1 processing is modulated by the mitochondrial membrane potential. Biol Cell. 2008 May;100(5):315–25. [PubMed]
48. Amutha B, Gordon DM, Gu Y, Pain D. A novel role of Mgm1p, a dynamin-related GTPase, in ATP synthase assembly and cristae formation/maintenance. Biochem J. 2004 Jul 1;381(Pt 1):19–23. [PubMed]
49. Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev Cell. 2002 Jan;2(1):55–67. [PubMed]
50. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003 Mar 7;278(10):7743–6. [PubMed]
51. Sesaki H, Southard SM, Yaffe MP, Jensen RE. Mgm1p, a dynamin-related GTPase, is essential for fusion of the mitochondrial outer membrane. Mol Biol Cell. 2003 Jun;14(6):2342–56. [PMC free article] [PubMed]
52. Kanazawa T, Zappaterra MD, Hasegawa A, Wright AP, Newman-Smith ED, Buttle KF, et al. The C. elegans Opa1 homologue EAT-3 is essential for resistance to free radicals. PLoS Genet. 2008 Feb;4(2):e1000022. [PMC free article] [PubMed]
53. Lee YJ, Jeong SY, Karbowski M, Smith CL, Youle RJ. Roles of the mammalian mitochondrial fission and fusion mediators Fis1, Drp1, and Opa1 in apoptosis. Mol Biol Cell. 2004 Nov;15(11):5001–11. [PMC free article] [PubMed]
54. Yoon Y, Krueger EW, Oswald BJ, McNiven MA. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol. 2003 Aug;23(15):5409–20. [PMC free article] [PubMed]
55. Serasinghe MN, Yoon Y. The mitochondrial outer membrane protein hFis1 regulates mitochondrial morphology and fission through self-interaction. Exp Cell Res. 2008 Nov 15;314(19):3494–507. [PMC free article] [PubMed]
56. Mozdy AD, McCaffery JM, Shaw JM. Dnm1p GTPase-mediated mitochondrial fission is a multi-step process requiring the novel integral membrane component Fis1p. J Cell Biol. 2000 Oct 16;151(2):367–80. [PMC free article] [PubMed]
57. Tieu Q, Nunnari J. Mdv1p is a WD repeat protein that interacts with the dynamin-related GTPase, Dnm1p, to trigger mitochondrial division. J Cell Biol. 2000 Oct 16;151(2):353–66. [PMC free article] [PubMed]
58. Griffin EE, Graumann J, Chan DC. The WD40 protein Caf4p is a component of the mitochondrial fission machinery and recruits Dnm1p to mitochondria. J Cell Biol. 2005 Jul 18;170(2):237–48. [PMC free article] [PubMed]
59. Labrousse AM, Zappaterra MD, Rube DA, van der Bliek AM. C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Mol Cell. 1999 Nov;4(5):815–26. [PubMed]
60. Smirnova E, Griparic L, Shurland DL, van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell. 2001 Aug;12(8):2245–56. [PMC free article] [PubMed]
61. Varadi A, Johnson-Cadwell LI, Cirulli V, Yoon Y, Allan VJ, Rutter GA. Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J Cell Sci. 2004 Sep 1;117(Pt 19):4389–400. [PubMed]
62. De Vos KJ, Allan VJ, Grierson AJ, Sheetz MP. Mitochondrial function and actin regulate dynamin-related protein 1-dependent mitochondrial fission. Curr Biol. 2005 Apr 12;15(7):678–83. [PubMed]
63. Ingerman E, Perkins EM, Marino M, Mears JA, McCaffery JM, Hinshaw JE, et al. Dnm1 forms spirals that are structurally tailored to fit mitochondria. J Cell Biol. 2005 Sep 26;170(7):1021–7. [PMC free article] [PubMed]
64. Zhu PP, Patterson A, Stadler J, Seeburg DP, Sheng M, Blackstone C. Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase Drp1. J Biol Chem. 2004 Aug 20;279(34):35967–74. [PubMed]
65. Yoon Y, Pitts KR, McNiven MA. Mammalian dynamin-like protein DLP1 tubulates membranes. Mol Biol Cell. 2001 Sep;12(9):2894–905. [PMC free article] [PubMed]
66. Damke H, Binns DD, Ueda H, Schmid SL, Baba T. Dynamin GTPase domain mutants block endocytic vesicle formation at morphologically distinct stages. Mol Biol Cell. 2001 Sep;12(9):2578–89. [PMC free article] [PubMed]
67. Eccleston JF, Binns DD, Davis CT, Albanesi JP, Jameson DM. Oligomerization and kinetic mechanism of the dynamin GTPase. Eur Biophys J. 2002 Jul;31(4):275–82. [PubMed]
68. Yoon Y, Pitts KR, Dahan S, McNiven MA. A novel dynamin-like protein associates with cytoplasmic vesicles and tubules of the endoplasmic reticulum in mammalian cells. J Cell Biol. 1998 Feb 23;140(4):779–93. [PMC free article] [PubMed]
69. Pitts KR, Yoon Y, Krueger EW, McNiven MA. The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells. Mol Biol Cell. 1999 Dec;10(12):4403–17. [PMC free article] [PubMed]
70. Karbowski M, Neutzner A, Youle RJ. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol. 2007 Jul 2;178(1):71–84. [PMC free article] [PubMed]
71. Nakamura N, Kimura Y, Tokuda M, Honda S, Hirose S. MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep. 2006 Oct;7(10):1019–22. [PubMed]
72. Yonashiro R, Ishido S, Kyo S, Fukuda T, Goto E, Matsuki Y, et al. A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics. EMBO J. 2006 Aug 9;25(15):3618–26. [PubMed]
73. Tondera D, Czauderna F, Paulick K, Schwarzer R, Kaufmann J, Santel A. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J Cell Sci. 2005 Jul 15;118(Pt 14):3049–59. [PubMed]
74. Tondera D, Santel A, Schwarzer R, Dames S, Giese K, Klippel A, et al. Knockdown of MTP18, a novel phosphatidylinositol 3-kinase-dependent protein, affects mitochondrial morphology and induces apoptosis. J Biol Chem. 2004 Jul 23;279(30):31544–55. [PubMed]
75. Hom JR, Gewandter JS, Michael L, Sheu SS, Yoon Y. Thapsigargin induces biphasic fragmentation of mitochondria through calcium-mediated mitochondrial fission and apoptosis. J Cell Physiol. 2007 Aug;212(2):498–508. [PubMed]
76. Harder Z, Zunino R, McBride H. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol. 2004 Feb 17;14(4):340–5. [PubMed]
77. Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem. 2007 Apr 13;282(15):11521–9. [PubMed]
78. Han XJ, Lu YF, Li SA, Tomizawa K, Takei K, Matsushita M, et al. Involvement of calcineurin in glutamate-induced mitochondrial dynamics in neurons. Neurosci Res. 2008 Jan;60(1):114–9. [PubMed]
79. Chang CR, Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem. 2007 Jul 27;282(30):21583–7. [PubMed]
80. Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 2007 Oct;8(10):939–44. [PubMed]
81. Cereghetti GM, Stangherlin A, Martins de Brito O, Chang CR, Blackstone C, Bernardi P, et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15803–8. [PubMed]
82. Garnier A, Fortin D, Zoll J, N’Guessan B, Mettauer B, Lampert E, et al. Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J. 2005 Jan;19(1):43–52. [PubMed]
83. Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, Catez F, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell. 2001 Oct;1(4):515–25. [PubMed]
84. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol. 2003 Mar 31;160(7):1115–27. [PMC free article] [PubMed]
85. James DI, Parone PA, Mattenberger Y, Martinou JC. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem. 2003 Sep 19;278(38):36373–9. [PubMed]
86. Yu T, Sheu SS, Robotham JL, Yoon Y. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc Res. 2008 Jul 15;79(2):341–51. [PMC free article] [PubMed]
87. Parra V, Eisner V, Chiong M, Criollo A, Moraga F, Garcia A, et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovasc Res. 2008 Jan 15;77(2):387–97. [PubMed]
88. Jiang S, Chow SC, Nicotera P, Orrenius S. Intracellular Ca2+ signals activate apoptosis in thymocytes: studies using the Ca(2+)-ATPase inhibitor thapsigargin. Exp Cell Res. 1994 May;212(1):84–92. [PubMed]
89. Kaneko Y, Tsukamoto A. Thapsigargin-induced persistent intracellular calcium pool depletion and apoptosis in human hepatoma cells. Cancer Lett. 1994 May 16;79(2):147–55. [PubMed]
90. Hussain SG, Ramaiah KV. Reduced eIF2alpha phosphorylation and increased proapoptotic proteins in aging. Biochem Biophys Res Commun. 2007 Apr 6;355(2):365–70. [PubMed]
91. Germain M, Mathai JP, McBride HM, Shore GC. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J. 2005 Apr 20;24(8):1546–56. [PubMed]
92. Takahashi Y, Karbowski M, Yamaguchi H, Kazi A, Wu J, Sebti SM, et al. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol. 2005 Nov;25(21):9369–82. [PMC free article] [PubMed]
93. Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, Nechushtan A, et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol. 2002 Dec 23;159(6):931–8. [PMC free article] [PubMed]
94. Wasiak S, Zunino R, McBride HM. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol. 2007 May 7;177(3):439–50. [PMC free article] [PubMed]
95. Arnoult D, Grodet A, Lee YJ, Estaquier J, Blackstone C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem. 2005 Oct 21;280(42):35742–50. [PubMed]
96. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell. 2008 Feb;14(2):193–204. [PMC free article] [PubMed]
97. Abdelwahid E, Yokokura T, Krieser RJ, Balasundaram S, Fowle WH, White K. Mitochondrial disruption in Drosophila apoptosis. Dev Cell. 2007 May;12(5):793–806. [PubMed]
98. Estaquier J, Arnoult D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis. Cell Death Differ. 2007 Jun;14(6):1086–94. [PubMed]
99. Goyal G, Fell B, Sarin A, Youle RJ, Sriram V. Role of mitochondrial remodeling in programmed cell death in Drosophila melanogaster. Dev Cell. 2007 May;12(5):807–16. [PMC free article] [PubMed]
100. Parone PA, James DI, Da Cruz S, Mattenberger Y, Donze O, Barja F, et al. Inhibiting the mitochondrial fission machinery does not prevent Bax/Bak-dependent apoptosis. Mol Cell Biol. 2006 Oct;26(20):7397–408. [PMC free article] [PubMed]
101. Wallace DC. Mitochondrial diseases in man and mouse. Science. 1999 Mar 5;283(5407):1482–8. [PubMed]
102. Waterham HR, Koster J, van Roermund CW, Mooyer PA, Wanders RJ, Leonard JV. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med. 2007 Apr 26;356(17):1736–41. [PubMed]
103. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000 Oct;26(2):211–5. [PubMed]
104. Pareyson D. Differential diagnosis of Charcot-Marie-Tooth disease and related neuropathies. Neurol Sci. 2004 Jun;25(2):72–82. [PubMed]
105. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000 Oct;26(2):207–10. [PubMed]
106. Anesti V, Scorrano L. The relationship between mitochondrial shape and function and the cytoskeleton. Biochim Biophys Acta. 2006 May–Jun;1757(5–6):692–9. [PubMed]
107. Twig G, Hyde B, Shirihai OS. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta. 2008 Sep;1777(9):1092–7. [PMC free article] [PubMed]
108. Diaz F, Moraes CT. Mitochondrial biogenesis and turnover. Cell Calcium. 2008 Jul;44(1):24–35. [PMC free article] [PubMed]
109. Santel A, Frank S, Gaume B, Herrler M, Youle RJ, Fuller MT. Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci. 2003 Jul 1;116(Pt 13):2763–74. [PubMed]
110. Rojo M, Legros F, Chateau D, Lombes A. Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo. J Cell Sci. 2002 Apr 15;115(Pt 8):1663–74. [PubMed]
111. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J, et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem. 2003 May 9;278(19):17190–7. [PubMed]
112. Stojanovski D, Koutsopoulos OS, Okamoto K, Ryan MT. Levels of human Fis1 at the mitochondrial outer membrane regulate mitochondrial morphology. J Cell Sci. 2004 Mar 1;117(Pt 7):1201–10. [PubMed]
113. Imoto M, Tachibana I, Urrutia R. Identification and functional characterization of a novel human protein highly related to the yeast dynamin-like GTPase Vps1p. J Cell Sci. 1998 May;111( Pt 10):1341–9. [PubMed]
114. Akepati VR, Muller EC, Otto A, Strauss HM, Portwich M, Alexander C. Characterization of OPA1 isoforms isolated from mouse tissues. J Neurochem. 2008 Jul;106(1):372–83. [PubMed]
115. Shimada T, Horita K, Murakami M, Ogura R. Morphological studies of different mitochondrial populations in monkey myocardial cells. Cell Tissue Res. 1984;238(3):577–82. [PubMed]
116. Palmer JW, Tandler B, Hoppel CL. Biochemical differences between subsarcolemmal and interfibrillar mitochondria from rat cardiac muscle: effects of procedural manipulations. Arch Biochem Biophys. 1985 Feb 1;236(2):691–702. [PubMed]
117. Sharma VK, Ramesh V, Franzini-Armstrong C, Sheu SS. Transport of Ca2+ from sarcoplasmic reticulum to mitochondria in rat ventricular myocytes. J Bioenerg Biomembr. 2000 Feb;32(1):97–104. [PubMed]
118. McCormack JG, Denton RM. The role of Ca2+ ions in the regulation of intramitochondrial metabolism and energy production in rat heart. Mol Cell Biochem. 1989 Sep 7;89(2):121–5. [PubMed]
119. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol. 2004 Oct;287(4):C817–33. [PubMed]
120. Matsuoka S, Sarai N, Jo H, Noma A. Simulation of ATP metabolism in cardiac excitation-contraction coupling. Prog Biophys Mol Biol. 2004 Jun–Jul;85(2–3):279–99. [PubMed]
121. Spat A, Szanda G, Csordas G, Hajnoczky G. High- and low-calcium-dependent mechanisms of mitochondrial calcium signalling. Cell Calcium. 2008 Jul;44(1):51–63. [PMC free article] [PubMed]
122. Scorrano L. Divide et impera: Ca2+ signals, mitochondrial fission and sensitization to apoptosis. Cell Death Differ. 2003 Dec;10(12):1287–9. [PubMed]
123. Saotome M, Safiulina D, Szabadkai G, Das S, Fransson A, Aspenstrom P, et al. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20728–33. [PubMed]
124. Wang X, Schwarz TL. The mechanism of Ca2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell. 2009 Jan 9;136(1):163–74. [PMC free article] [PubMed]
125. de Brito OM, Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature. 2008 Dec 4;456(7222):605–10. [PubMed]
126. Chung S, Dzeja PP, Faustino RS, Perez-Terzic C, Behfar A, Terzic A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med. 2007 Feb;4( Suppl 1):S60–7. [PMC free article] [PubMed]
127. Shepard TH, Muffley LA, Smith LT. Ultrastructural study of mitochondria and their cristae in embryonic rats and primate (N. nemistrina) Anat Rec. 1998 Nov;252(3):383–92. [PubMed]
128. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991 Feb;83(2):504–14. [PubMed]
129. Scholz D, Diener W, Schaper J. Altered nucleus/cytoplasm relationship and degenerative structural changes in human dilated cardiomyopathy. Cardioscience. 1994 Jun;5(2):127–38. [PubMed]
130. Ausma J, Thone F, Dispersyn GD, Flameng W, Vanoverschelde JL, Ramaekers FC, et al. Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem. 1998 Sep;186(1–2):159–68. [PubMed]
131. Kalra DK, Zoghbi WA. Myocardial hibernation in coronary artery disease. Curr Atheroscler Rep. 2002 Mar;4(2):149–55. [PubMed]
132. Trillo AA, Holleman IL, White JT. Presence of satellite cells in a cardiac rhabdomyoma. Histopathology. 1978 May;2(3):215–23. [PubMed]
133. Jones M, Ferrans VJ, Morrow AG, Roberts WC. Ultrastructure of crista supraventricularis muscle in patients with congenital heart diseases associated with right ventricular outflow tract obstruction. Circulation. 1975 Jan;51(1):39–67. [PubMed]
134. Terman A, Dalen H, Eaton JW, Neuzil J, Brunk UT. Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann N Y Acad Sci. 2004 Jun;1019:70–7. [PubMed]
135. Twig G, Graf SA, Wikstrom JD, Mohamed H, Haigh SE, Elorza A, et al. Tagging and tracking individual networks within a complex mitochondrial web with photoactivatable GFP. Am J Physiol Cell Physiol. 2006 Jul;291(1):C176–84. [PubMed]
136. McCormack JG, Denton RM. The role of intramitochondrial Ca2+ in the regulation of oxidative phosphorylation in mammalian tissues. Biochem Soc Trans. 1993 Aug;21(Pt 3 3):793–9. [PubMed]
137. Das AM, Harris DA. Intracellular calcium as a regulator of the mitochondrial ATP synthase in cultured cardiomyocytes. Biochem Soc Trans. 1990 Aug;18(4):554–5. [PubMed]